E178: Elon Musk of Biotech: How David Berry Built 7 Unicorns
David Berry is one of the most prolific healthcare entrepreneurs of our time. In this episode, we discuss his transition from scientist to founder to investor, what it takes to scale transformational health companies, and how his firm Averin is helping usher in the next wave of AI-enabled healthcare. We also talk…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from How I Invest with David Weisburd
See all episodes →
E433: AlphaSense’s Chris Ackerson on AI, the Future of Finance & Finding Alpha
E432: $24 Billion Investor on Private Credit, the Psychology of Winning & Fear of Failure
E431: Marty Kausas on AI, Trillion Dollar Startups & Founder Psychology
Similar episodes from other shows
More like How I Invest with David Weisburd →
D.A. Wallach Explains Why Biotech VC Is So Different
Y Combinator CEO Garry Tan: Turning Ambitious Misfits into Founders
Sequoia's Roelof Botha: Why Venture Capital is Broken & How Great Companies Are Built
Full Interview: Bill Gurley Thinks College Kills Creativity
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.